Loading chat...
NY S01193
Bill
Status
Engrossed
6/1/2023
Primary Sponsor
Roxanne Persaud
Click for details
AI Summary
- Adds new Public Health Law section 2404-e prohibiting denial of genetic testing or genomic tumor profiling to individuals with a personal history of ovarian cancer
- Removes frequency caps and other limitations on genetic and genomic testing for ovarian cancer survivors
- Requires testing to include BRCA1 and BRCA2 gene mutations, Lynch syndrome-associated mutations, rearrangement analysis of coding exons related to ovarian cancer, and additional mutations deemed medically necessary by treating health care professionals
- Takes effect immediately upon enactment
Legislative Description
Ensures ovarian cancer survivors have the right to access screenings for health conditions.
Last Action
referred to health
5/29/2024
Committee Referrals
Health5/29/2024
Finance3/6/2024
Women's Issues1/3/2024
Health6/1/2023
Finance1/23/2023
Women's Issues1/10/2023
Full Bill Text
No bill text available